First Generic Flu Pill Approved for Single-Dose Treatment

Getting the flu no longer means a week of multiple daily medications thanks to a breakthrough FDA approval.

The Food and Drug Administration approved the first generic version of baloxavir marboxil tablets, the only single-dose flu treatment available in the United States. Patients five and older can now take just one pill to treat acute flu or prevent it after exposure to someone who's sick.

The approval arrives just in time for the 2026-2027 flu season. Dr. Iilun Murphy, Director of the Office of Generic Drugs, called it a meaningful milestone for influenza treatment, especially given that the flu causes millions of illnesses across America every year.

The medication works when taken within 48 hours of showing flu symptoms. It treats otherwise healthy patients as well as those at high risk for flu complications, giving families a simpler option than traditional multi-day antiviral courses.

Generic versions of medications create competition that drives down prices. Nine out of ten prescriptions filled in America are already generics, helping patients access treatments they might not otherwise afford.

The single-dose approach solves a common problem with flu treatment. Many patients stop taking medications once they start feeling better, but this pill eliminates the challenge of remembering multiple doses over several days.

The Ripple Effect

This approval demonstrates how generic drug competition transforms healthcare access. When families can afford effective flu treatment with a single pill, fewer people miss work or school. Fewer complications develop. Emergency rooms see less strain during peak flu season.

The medication can also prevent flu in people exposed to infected family members or coworkers. This prophylactic use could help stop the spread of influenza through households and communities, protecting vulnerable people before they even get sick.

Healthcare providers now have a powerful tool that combines convenience with effectiveness. The simplicity of one dose means better patient compliance and potentially fewer flu-related hospitalizations across the country.

Common side effects include diarrhea, headaches, and nausea, but the medication carries standard safety warnings that doctors know how to manage. Patients with known allergies to the drug's ingredients should avoid it.

As with any medication, people should consult their healthcare providers about whether this treatment suits their specific situation. But for millions facing another flu season, a single-pill solution just became far more accessible.